Torres, Mark Jezer .

HRN: 27-39-92  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/27/2026
CEFTRIAXONE 1G (VIAL)
01/27/2026
02/03/2026
IV
2g
Od
Pne
Remove - Pending Acceptance
01/27/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
01/27/2026
02/03/2026
IV
500MG
Q8H
EMPYEMA
Remove - Pending Acceptance
01/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/27/2026
02/03/2026
IV
500MG
Q8H
EMPYEMA
Remove - Pending Acceptance
02/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
02/05/2026
02/11/2026
IVTT
4.5 G
Q6
Cap-MR
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: